|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Okuda K: Hepatocellular carcinoma. J
Hepatol. 32:225–237. 2000. View Article : Google Scholar
|
|
3
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar
|
|
4
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lai EC and Lau WY: The continuing
challenge of hepatic cancer in Asia. Surgeon. 3:210–215. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thompson LU, Chen JM, Li T,
Strasser-Weippl K and Goss PE: Dietary flaxseed alters tumor
biological markers in postmenopausal breast cancer. Clin Cancer
Res. 11:3828–3835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JB, Lee MS, Cha EY, et al:
Magnolol-induced apoptosis in HCT-116 colon cancer cells is
associated with the AMP-activated protein kinase signaling pathway.
Biol Pharm Bull. 35:1614–1620. 2012.PubMed/NCBI
|
|
8
|
Kuijsten A, Arts IC, Hollman PC, van’t
Veer P and Kampman E: Plasma enterolignans are associated with
lower colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev.
15:1132–1136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Adlercreutz H: Lignans and human health.
Crit Rev Clin Lab Sci. 44:483–525. 2007. View Article : Google Scholar
|
|
10
|
Bergman Jungestrom M, Thompson LU and
Dabrosin C: Flaxseed and its lignans inhibit estradiol-induced
growth, angiogenesis, and secretion of vascular endothelial growth
factor in human breast cancer xenografts in vivo. Clin Cancer Res.
13:1061–1067. 2007.PubMed/NCBI
|
|
11
|
Cuca LE, Coy ED, Alarcón MA, Fernández A
and Aristizábal FA: Cytotoxic effect of some natural compounds
isolated from Lauraceae plants and synthetic derivatives.
Biomedica. 31:335–343. 2011.PubMed/NCBI
|
|
12
|
Zhou Y, Liu YE, Cao J, et al: Vitexins,
nature-derived lignan compounds, induce apoptosis and suppress
tumor growth. Clin Cancer Res. 15:5161–5169. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Z, Xiao Y, Yuan Y, et al: Effects of
oleic acid on cell proliferation through an integrin-linked kinase
signaling pathway in 786-O renal cell carcinoma cells. Oncol Lett.
5:1395–1399. 2013.PubMed/NCBI
|
|
14
|
Vene R, Benelli R, Minghelli S, Astigiano
S, Tosetti F and Ferrari N: Xanthohumol impairs human prostate
cancer cell growth and invasion and diminishes the incidence and
progression of advanced tumors in TRAMP mice. Mol Med.
18:1292–1302. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rubinfeld H, Cohen-Kaplan V, Nass D, et
al: Heparanase is highly expressed and regulates proliferation in
GH-secreting pituitary tumor cells. Endocrinology. 152:4562–4570.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu J, Wu X, Zhong D, Zhai W, Ding Z and
Zhou Y: Short hairpin RNA (shRNA) Ether à go-go 1 (Eag1) inhibition
of human osteosarcoma angiogenesis via VEGF/PI3K/AKT signaling. Int
J Mol Sci. 13:12573–12583. 2012.
|
|
17
|
Khaidakov M and Mehta JL: Oxidized LDL
triggers pro-oncogenic signaling in human breast mammary epithelial
cells partly via stimulation of MiR-21. PLoS One. 7:e469732012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Dijk M, van Bezu J, van Abel D, et al:
The STOX1 genotype associated with pre-eclampsia leads to a
reduction of trophoblast invasion by alpha-T-catenin upregulation.
Hum Mol Genet. 19:2658–2667. 2010.PubMed/NCBI
|
|
19
|
Biggs WH III, Meisenhelder J, Hunter T,
Cavenee WK and Arden KC: Protein kinase B/Akt-mediated
phosphorylation promotes nuclear exclusion of the winged helix
transcription factor FKHR1. Proc Natl Acad Sci USA. 96:7421–7426.
1999. View Article : Google Scholar
|
|
20
|
Band AM, Björklund M and Laiho M: The
phosphatidylinositol 3-kinase/Akt pathway regulates transforming
growth factor-{beta} signaling by destabilizing ski and inducing
Smad7. J Biol Chem. 284:35441–35449. 2009.
|
|
21
|
Wang L, Jia D, Duan F, et al: Combined
anti-tumor effects of IFN-alpha and sorafenib on hepatocellular
carcinoma in vitro and in vivo. Biochem Biophys Res Commun.
422:687–692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vanbrocklin MW, Robinson JP, Lastwika KJ,
McKinney AJ, Gach HM and Holmen SL: Ink4a/Arf loss promotes tumor
recurrence following Ras inhibition. Neuro Oncol. 14:34–42. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim BC: FoxO3a mediates transforming
growth factor-beta1-induced apoptosis in FaO rat hepatoma cells.
BMB Rep. 41:728–732. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang S, Chong ZZ, Shang YC and Maiese K:
WISP1 neuroprotection requires FoxO3a post-translational modulation
with autoregulatory control of SIRT1. Curr Neurovasc Res. 10:54–69.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liang C, Chen W, Zhi X, et al: Serotonin
promotes the proliferation of serum-deprived hepatocellular
carcinoma cells via upregulation of FOXO3a. Mol Cancer. 12:142013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Naka K, Hoshii T, Muraguchi T, et al:
TGF-beta-FOXO signalling maintains leukaemia-initiating cells in
chronic myeloid leukaemia. Nature. 463:676–680. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Jiang H, Gao H, et al: The
monoclonal antibody CH12 enhances the sorafenib-mediated growth
inhibition of hepatocellular carcinoma xenografts expressing
epidermal growth factor receptor variant III. Neoplasia.
14:509–518. 2012.
|
|
28
|
Chung YW, Kim HK, Kim IY, Yim MB and Chock
PB: Dual function of protein kinase C (PKC) in
12-O-tetradecanoylphorbol-13-acetate (TPA)-induced manganese
superoxide dismutase (MnSOD) expression: activation of CREB and
FOXO3a by PKC-alpha phosphorylation and by PKC-mediated
inactivation of Akt, respectively. J Biol Chem. 286:29681–29690.
2011.
|
|
29
|
Kashiwagi A, Fein MJ and Shimada M:
Calpain modulates cyclin-dependent kinase inhibitor 1B (p27(Kip1))
in cells of the osteoblast lineage. Calcif Tissue Int. 89:36–42.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dormond O, Madsen JC and Briscoe DM: The
effects of mTOR-Akt interactions on anti-apoptotic signaling in
vascular endothelial cells. J Biol Chem. 282:23679–23686. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Davis R, Singh KP, Kurzrock R and Shankar
S: Sulforaphane inhibits angiogenesis through activation of FOXO
transcription factors. Oncol Rep. 22:1473–1478. 2009.PubMed/NCBI
|
|
32
|
Wu HH, Wu JY, Cheng YW, et al: cIAP2
upregulated by E6 oncoprotein via epidermal growth factor
receptor/phosphatidylinositol 3-kinase/AKT pathway confers
resistance to cisplatin in human papillomavirus 16/18-infected lung
cancer. Clin Cancer Res. 16:5200–5210. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kreutzer JN, Ruzzene M and Guerra B:
Enhancing chemosensitivity to gemcitabine via RNA interference
targeting the catalytic subunits of protein kinase CK2 in human
pancreatic cancer cells. BMC Cancer. 10:4402010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fleischer B, Schulze-Bergkamen H,
Schuchmann M, et al: Mcl-1 is an anti-apoptotic factor for human
hepatocellular carcinoma. Int J Oncol. 28:25–32. 2006.PubMed/NCBI
|
|
35
|
He L, Yang X, Cao X, Liu F, Quan M and Cao
J: Casticin induces growth suppression and cell cycle arrest
through activation of FOXO3a in hepatocellular carcinoma. Oncol
Rep. 29:103–108. 2013.PubMed/NCBI
|
|
36
|
Nayak G and Cooper GM: p53 is a major
component of the transcriptional and apoptotic program regulated by
PI 3-kinase/Akt/GSK3 signaling. Cell Death Dis. 3:e4002012.
View Article : Google Scholar : PubMed/NCBI
|
